Loading organizations...
Loading organizations...
Biotechnology company developing therapeutic exosomes for various diseases.
ILIAS Biologics has raised $20.6M across 1 funding round.
ILIAS Biologics has raised $20.6M in total across 1 funding round.
ILIAS Biologics has raised $20.6M in total across 1 funding round.
ILIAS Biologics's investors include Asset One, Daedeok Venture Partners, Daishin Private Equity, Dev Sisters Ventures, Genie Asset Management, Hanyang Securities/Yeolim Partners, HB Investment, Kiwoom Securities, Meritz Securities, Timefolio Asset Management.
ILIAS Biologics has raised $20.6M across 1 funding round. Most recently, it raised $20.6M Series B in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2020 | $20.6M Series B | Asset One, Daedeok Venture Partners, Daishin Private Equity, Dev Sisters Ventures, Genie Asset Management, Hanyang Securities/Yeolim Partners, HB Investment, Kiwoom Securities, Meritz Securities, Timefolio Asset Management |